Centro Andaluz de Biología Molecular y Medicina Regenerativa

Pancreatic islets and stem cells

Research Lines

Cell-replacement therapy appears as an attractive approach to treat diabetes and thus, has become a major goal in the field of diabetes research. Unfortunately, there is a shortage of beta cells obtained from human cadaveric donors. Thus, it is important to identify alternative sources of functional beta cells. In this sense, research in our lab focuses on the use of stem and/or progenitor cells to obtain insulin-producing beta cells. To this end, we work on the following research lines:Transcriptional control in pancreas development

In recent studies about endoderm-derived cells from embryonic stem cells (ES) cells, it has been shown that information gathered from the field of developmental biology has been crucial for the design of in vitro differentiation strategies, including the generation of insulin-producing cells. In spite of the importance of these studies, the signaling pathways and transcriptional factors involved in the early endoderm development are not well defined yet. Among the transcriptions factors that have been shown to be important for early endoderm development and pancreas is GATA4. In spite of the importance of GATA4 for endoderm development and its derivatives, little is known about its transcriptional regulation. As a first step to understand the transcriptional network operating in the early endoderm and in the pancreatic endoderm, we are analyzing the transcriptional regulation of GATA4 in endoderm development via identified GATA4 enhancers, which are able to direct expression to the early endoderm (A) and developing pancreas (B) in transgenic mice.

Role of GATA4 transcription factor in endoderm and pancreas development

GATA4 null mice die at early stages of development. The early lethality of the Gata4 knockout embryos impairs a detailed analysis of the role of GATA4 in endoderm-derived organs. Although recent reports have suggested a role of GATA4 in pancreatic endoderm development, the precise role and the mechanisms by which this transcription factor contributes to the earliest steps of pancreas development are not clear yet. We hypothesize that GATA4 might contribute to pancreas specification by activating Pdx1 promoter expression in the pre-pancreatic endoderm. To test this hypothesis we are analyzing embryonic developing pancreas of Gata4 conditional knockout, which are generated by Cre/loxP technology.

Obtention of insulin-secreting cells from adult pancreatic stem cells or progenitor cells

ß cells could be (re-)generated by stimulation of ß cell replication and/or differentiation of stem/progenitor cells. The studies suggest that, during adult life, the principal mode of ß-cell replacement is the replication of pre-existing ß cells. However, other reports show that ß-cell can also be formed from alternative source of ß cell neogenesis. In vitro proliferation of insulin-secreting cells derived from adult human and mouse islets have already been achieved using different external stimuli and culture techniques. However, success in expansion of functional insulin-producing cells in vitro has been limited. In addition, culture of adult islets results in loss of ß cell phenotype, apoptosis and senescence. Thus, general objective of this project is to develop protocols that allow us the expansion of ß cell mass in cultured adult islets and to identify the cellular origin of new ß cells. These studies will contribute to develop protocols able to increase the proliferative potential of ß cells. This could provide novel methods for expanding ß cell mass. Once established, these methods would aid in the design of regenerative and cellular therapies for diabetes.

Obtention of insulin-producing cells from peripheral human blood monocytes

The possibility that bone marrow, cord-blood or peripheral blood cells are capable of progressing to insulin producing cells has raised a fascinating question about developmental plasticity. In fact, adult stem cells able to transdifferentiate into ?-like cells have been isolated from bone marrow and umbilical cord blood. . In addition, in cells derived from unmobilised adult human peripheral blood a population of pluripotent stem cells with multi-developmental potential has been isolated. Finally, recent report from our group studied the unexpected plasticity of monocytes, in order to derive insulin-producing cells from human peripheral blood. These cells expressed beta cell specific transcription factors, secreted insulin and C-peptide in a glucose-dependent manner and normalized blood glucose levels, during one week, when transplanted in streptozotocin diabetic mice. This study opens a real possibility of the clinical application of these cells. In this project, we explore the clinical potential of these cells in order to be used in diabetes cell therapy.

Funding

CIBER de Diabetes y Enfermedades Metabólicas. Instituto de Salud Carlos III.

Instituto de Salud Carlos III.
Ministerio de Ciencia e Innovación.
Consejería de Salud, Junta de Andalucía.
Universidad Pablo Olavide.

Soria B., Roche E., León-Quinto T., Berná G., Reig J.A. and Martín F. (2000) Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin induced diabetic mice. Diabetes 49: 157-162

Penalva L., Ruiz MF., Ortega A., Granadino B., Vicente L., Segarra C., Valcárcel J and Sanchez J. (2000) The Drosophila fl(2)d gene, required for female-specific splicing of Sxi and Tra pre-mRNAs, encodes a novel nuclear protein with a HQ-rich domain. Genetics 155: 129-139

Soria B., Real F.X. and Martín F. (2001) From stem cells to B-cells: new strategies in cell therapy of diabetes mellitus. Diabetologia 44: 407-415

Vaca P., Berna G., Martín F. and Soria B. (2003) Nicotinamide induces both proliferation and differentiation of embryonic stem cells into insulin-producing cells. Transpl. Proc. 35: 2021-2023

Ortega A., Niksic M., Bachi A., Wilm M., Sanchez L., Hastie N. and Valcarcel J. (2003) Biochemical function of Female-Lethal(2)D / Wilms’ Tumor Suppressor-1 Associated proteins in alternative pre-mRNA splicing. J. Biol.Chem. 278: 3040-3047

Skoudy A., Rovira M., Savatier P., Martin F., León-Quinto T., Soria B. and Real F.X. (2004) TGF?, FGF and retinoid signalling pathways promote pancreatic exocrine gene expression in mouse embryonic stem cells. Biochem. J. 379: 749-756

Ruhnke M., Ungefroren H., Nussler A., Klapper W., Martin F., Ulrichs K., Hutchinson JA., Soria B., Zehle G., Parwaresch RM., Heeckt P., Kremer B. and Fändrich F. (2005) Reprogramming of human peripheral blood monocytes into functional hepatocyte and pancreatic islet-like cells. Gastroenterology 128: 1774-1786

Soria B., Bedoya F.J. and Martín F. (2005) Pancreatic stem cells. American Journal of Physiology 289: G177-G180

Rojas A., De Val S., Heidh A. B., Xu S-M., Bristow J and Black, B. L. (2005) Gata4 expression in lateral mesoderm is downstream of BMP4 and is activated directly by Forkhead and GATA transcription factors through a distal enhancer element. Development 132: 3405-3417

Vaca P., Martin F., Vegara-Meseguer J., Rovira J.M. Berna G. and Soria B. (2006) Induction of differentiation of embryonic stem cells into insulin secreting cells by fetal soluble factors. Stem Cells 24: 258-265

Heidt A.B., Rojas A., Harris I. and Black B.L. (2007) Determinants of myogenic specificity within MyoD are required for non-canonical E Box binding. Mol. Cell. Biol. 27: 5910-20

Rojas A. and Black B. L. (2008). Transcriptional Control of Cardiac Boundaries Formation. In Advances in Developmental Biology 4: 93-116

Rojas A., Kong S-W, Agarwal P., Gillis B., Pu W.T. and Black, B.L. (2008) Gata4 is a direct transcriptional activator of Cyclin D2 and Cdk4 and is required for cardiomyocyte proliferation in the second heart field-derived myocardium. Mol. Cell. Biol. 28: 5420-31

Vaca P., Berná G., Carneiro EM., Soria B. and Martín F. (2008) Nicotinamide induces differeniation of embryonic stem cells into insulin-secreting cells. Exp. Cell Res. 314: 969-974

Soria B., Bedoya FJ., Tejedo JR., Hmadcha K., Salmeron-Ruiz R., Lim S. and Martín F. (2008) Cell therapy of diabetes mellitus: an opportunity of stem cells?. Cells Tissue Organ 188: 70-77

Patents

Inventors: B. Soria, F. Martín, J.A. Reig, G. Berná, R. Enseñat-Wasser. Title: “Pluripotent adult stem cell from regenerative tissue”. Registration number: EP 01-1001-333.1. Registration date: 22-01-01. Countries: Europe, USA, Canada, India. Explotation: CardioGene AG

Inventors: F.J. Navarro, F. Martín, P. Moreno, V. Rivero, E. Leon. Title: “Composition for prevention or treatment of Diabetes Mellitus”. Registration number: P200900829. Registration date: 09-03-09. Countries: Europe

Group leader:
  • Dr. Franz Martín Bermudo
Postdoctorals:
  • Dr. Amparo Luque Sierra
PhD students:
  • Leticia Álvarez Amor
Technicians:
  • Raquel Araujo Legido
  • Antonio Manuel Cárdenas García
  • Lucía López Bermudo